By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen will provide molecular diagnostics screening to women in Rwanda as part of a national cervical cancer prevention effort announced today.

As part of the initiative announced by Merck, Qiagen, and the government of Rwanda, Qiagen will provide screening for women between the ages of 35 and 45, and Merck will vaccinate girls between 12 and 15 years of age during the first three years of the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.